Single dose, polymeric, microparticle-based vaccines: The influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen

Vaccine

Volumn 14, Issue 15, 1996, Pages 1429-1438

  Coombes, A G A ^a   Lavelle, E C ^a   Jenkins, P G ^b   Davis, S S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Proteus Molecular Design   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G; MICROSPHERE; OVALBUMIN; POLYMER; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; VACCINATION;

ALUM COMPOUNDS; ANIMALS; ANTIBODIES; BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; IMMUNOGLOBULIN G; LACTIC ACID; MICE; MICROSPHERES; OVALBUMIN; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; VACCINES;

EID: 0030445728     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00077-1     Document Type: Article

References (35)

1. 1 Aguado, M.T. and Lambert, P.H. Controlled release vaccines-biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles. Immunobiology 1992, 184, 113-125
2. 2 Stieneker, F., Kersten, G., van Bloois, L. et al. Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations. Vaccine 1995, 13, 45-53
3. 3 O'Hagan, D.T., Jeffery, H. and Davis, S.S. Long term antibody responses in mice following subcutaneous immunisation with ovalbumin entrapped in biodegradable microparticles. Vaccine 1993, 11, 965-969
4. 4 Uchida, T., Martin, S., Foster, T.P., Wardley, R.C. and Grimm, S. dose and load studies for subcutaneous and oral delivery of poly(lactide co-glycolide) microspheres containing ovalbumin. Pharm. Res. 1994, 11, 1009-1015
5. 5 Vordermeier, M., Coombes, A.G.A., Jenkins, P. et al. Synthetic delivery systems for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine 1995, 13, 1576-1582
6. 6 Alonso, M.J., Cohen, S., Park, T.J. and Langer, R.S. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 1993, 10, 945-953
7. 7 Espartza, I. and Kissel, T. Parameters affecting, the immunogenicity of microencapsulated tetanus toxoid. Vaccine 1992, 10, 714-720
8. 8 Raghuvanshi, R.S., Singh, M. and Talwar, G.P. Biodegradable delivery system for single step immunisatuion with tetanus toxoid. Int. J. Pharm. 1993, 93, R1-R5
9. 9 Singh, M., Singh, O., Singh, A. and Talwar, G.P. Immunogenicity studies on diptheria toxoid loaded biodegradable microspheres. Int. J. Pharm. 1992, 85, R5-R8
10. 10 Eldridge, J.H., Staas, K., Meulbroek, J.A., McGhee, R., Tice, T.R. and Gilley, R.M. Biodegradable microspheres as a vaccine delivery system. Molec. Immun. 1991, 28, 287-294
11. 11 Coombes, A.G.A. and Meikle, M.C. Resorbable synthetic polymers as replacements for bone graft. Clin. Mater. 1994, 17, 35-67
12. 12 Hoppen, H.J., Leenslag, J.W., Pennings, A.J., Van der Lei, B. and Robinson, P.H. Two-ply biodegradable nerve guide: basic aspects of design, construction and biological performance. Biomaterials 1990, 11, 286-290
13. 13 Reul, G.J. Use of vicryl (polyglactin 910) sutures in general surgical and cardiothoracic procedures. Am. J. Surg. 1977, 134, 297
14. 14 Lewis, D.H. Controlled Release of Bioactive Agents from Lactide/glycolide Polymers (Eds Chasin, H. and Langer R.). Marcel Dekker, New York, 1990, pp. 1-41
15. 15 Jalil, R. and Nixon, J.R. Biodegradable poly(lactic acid) and poly(lactide co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencaps. 1990, 7, 297-325
16. 16 Vranken, M.N. and Claeys, D.A. Methods for encapsulating water and aqueous phase by extraction. U.S. Patent 3523907, 1970
17. 17 Ogawa, Y., Yamamoto, M., Okada, H., Yashiki, T. and Shimamoto, T. A new technique to efficiently entrap leuprolide acetate into microcapsules of copolylactic/glycolic acid. Chem. Pharm. Bull. 1988, 36, 1095-1103
18. 18 Washington, C. Particle Size Analysis in Pharmaceutics and Other Industries, Theory and Practice. Ellis Horwood, Chichester, 1992, Chap. 7
19. 19 O'Hagan, D.T., Jeffery, H. and Davis, S.S. The preparation and characterisation of poly(lactide co-glycolide) microparticles. 3, Microparticle/polymer degradation rates and the in vitro release of a model protein. Int. J. Pharm. 1994, 103, 37-45
20. 20 Smith, P.K. et al. Measurement of protein using bicinchoninic acid. Analyt. Biochem. 1985, 150, 76
21. 21 Challacombe, S.J., Rahman, D., Jeffery, H., Davis, S.S. and O'Hagan, D.T. Enhanced secretory IgA and systemic IgG antibody responses after oral immunisation with biodegradable microparticles containing antigen. Immunology 1992, 76, 164-168
22. 22 Russell-Jones, G.J. and Jeffery, H. In-vitro characterisation of biodegradable microparticles for oral antigen delivery. Proc. Int. Symp. Contr. Rel. Bioact. Mater. 1994, 21, 873-874
23. 23 Verrechia, T., Huve, P., Bazile, D., Veillard, M., Spenlehauer, G. and Couvreur, P. Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. J. Biomed. Mater. Res. 1993, 27, 1019-1028
24. 24 Khan, M.Z.I., Optebeeck, J.P. and Tucker, I.G. Immunopotentiation and delivery systems for antigens for single-step immunisation. Recent Trends Progr. Pharm. Res. 1994, 11, 2-11
25. 25 Gray, D. and Skarvall, H. B-cell memory is short lived in the absence of antigen. Nature 1988, 336, 70
26. 26 Langer, R. Polymers for the sustained release of macromolecules. Their use in a single step method of immunisation. Meth. Enzym. 1981, 73, 57-75
27. 27 Park, T.G., Lu, W.L. and Crotts, G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(DL lactic acid co-glycolic acid) microspheres. J. Contr. Rel. 1995, 33, 211-222
28. 6, LHRH a decapeptide onto glass and other surfaces. Int. J. Pharm. 1983, 16, 181-190
29. 29 Sah, H., Toddywala, R. and Chien, Y.W. The influence of biodegradable microcapsule formulations on the controlled release of a protein. J. Contr. Release 1994, 30, 201-211
30. 30 Alpar, H.O. and Almeida, A.J. Identification of some of the physico-chemical characteristics of microspheres which influence the induction of the immune response following mucosal delivery. Eur. J. Pharm. Biopharm. 1994, 40, 198-202
31. 31 Hunter, R., Olsen, M. and Buynitzky, S. Adjuvant activity of non-ionic block copolymers.IV Effect of molecular weight and formulation on titre and isotype of antibody. Vaccine 1991, 9, 250-256
32. 32 Kreuter, J., Liehl, E., Berg, U., Soliva, M. and Speiser, P.P. Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants. Vaccine 1988, 6, 253-256
33. 33 Eldridge, J.H., Staas, J.K., Meulbroek, J.A., Tice, T.R. and Gilley, R.M. Biodegradable and biocompatible poly(dl lactide co-glycolide) microspheres as an adjuvant for Staphylococcal Enterotoxin B toxoid which enhances the level of toxin-neutralising antibodies. Infect. Immun. 1991, 59, 2978-2986
34. 34 Tabata, Y. and Ikada, Y. Protein precoating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation. Pharm. Res. 1989, 6, 296-301
35. 35 Cohen, S., Bernstein, C., Hewes, C., Chow, M. and Langer, R. The pharmacokinetics of and humoral response to antigen delivered by microencapsulated liposomes. Proc. Natl. Acad. Sci. USA 1991, 88, 10440-10444